Clinical trial
A Prospective, Randomized and Multi-center Clinical Study to Evaluate Efficacy and Safety of Combination Therapy of Mitiglinide or Voglibose With Long-acting Insulin in Type 2 Diabetic Patients
NCT00663884 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized and Multi-center Clinical Study to Evaluate Efficacy and Safety of Combination Therapy of Mitiglinide or Voglibose With Long-acting Insulin in Type 2 Diabetic Patients
- Lead sponsor
- JW Pharmaceutical
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- September 30, 2009
- Enrollment
- 167 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.